Citations (21)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (15)
Syed A Hussain, Daniel H Palmer, Sarah Moon & Daniel W Rea. (2004) Endocrine therapy and other targeted therapies for metastatic breast cancer. Expert Review of Anticancer Therapy 4:6, pages 1179-1195.
Read now
Read now
John T Lee Jr & James A McCubrey. (2002) Targeting the Raf kinase cascade in cancer therapy – novel molecular targets and therapeutic strategies. Expert Opinion on Therapeutic Targets 6:6, pages 659-678.
Read now
Read now
Mercedes Dosil, Loïc Giot, Colleen Davis & James B. Konopka. (1998) Dominant-Negative Mutations in the G-Protein-Coupled α-Factor Receptor Map to the Extracellular Ends of the Transmembrane Segments. Molecular and Cellular Biology 18:10, pages 5981-5991.
Read now
Read now
Guadalupe Bilbao & David T Curiel. (1996) Section Review Oncologic, Endocrine & Metabolic: Gene therapy for cancer therapeutics. Expert Opinion on Therapeutic Patents 6:12, pages 1267-1284.
Read now
Read now
Petra I. Knaus, Dirk Lindemann, John F. DeCoteau, Riki Perlman, Haya Yankelev, Merrill Hille, Marshall E. Kadin & Harvey F. Lodish. (1996) A Dominant Inhibitory Mutant of the Type II Transforming Growth Factor β Receptor in the Malignant Progression of a Cutaneous T-Cell Lymphoma. Molecular and Cellular Biology 16:7, pages 3480-3489.
Read now
Read now
Antoni Wiedłocha, Pål Ø. Falnes, Andrzej Rapak, Raquel Muñoz, Olav Klingenberg & Sjur Olsnes. (1996) Stimulation of Proliferation of a Human Osteosarcoma Cell Line by Exogenous Acidic Fibroblast Growth Factor Requires both Activation of Receptor Tyrosine Kinase and Growth Factor Internalization. Molecular and Cellular Biology 16:1, pages 270-280.
Read now
Read now
Nissim Benvenisty & David M. Ornitz. (1995) BK1: An FGF-Responsive Central Nervous System-Derived Cell Line. Growth Factors 12:1, pages 49-55.
Read now
Read now
Yan Li, Claudio Basilico & Alka Mansukhani. (1994) Cell Transformation by Fibroblast Growth Factors Can Be Suppressed by Truncated Fibroblast Growth Factor Receptors. Molecular and Cellular Biology 14:11, pages 7660-7669.
Read now
Read now
Stephanie S. Watowich, Douglas J. Hilton & Harvey F. Lodish. (1994) Activation and Inhibition of Erythropoietin Receptor Function: Role of Receptor Dimerization. Molecular and Cellular Biology 14:6, pages 3535-3549.
Read now
Read now
Dwayne L. Barber, John C. DeMartino, Mark O. Showers & Alan D. D'Andrea. (1994) A Dominant Negative Erythropoietin (EPO) Receptor Inhibits EPO-Dependent Growth and Blocks F-gp55-Dependent Transformation. Molecular and Cellular Biology 14:4, pages 2257-2265.
Read now
Read now
Ergang Shi, Mikio Kan, Jianming Xu, Fen Wang, Jinzhao Hou & Wallace L. McKeehan. (1993) Control of Fibroblast Growth Factor Receptor Kinase Signal Transduction by Heterodimerization of Combinatorial Splice Variants. Molecular and Cellular Biology 13:7, pages 3907-3918.
Read now
Read now
Gary K. Scott, Robert Robles, John W. Park, Pamela A. Montgomery, Janice Daniel, William E. Holmes, James Lee, Gilbert A. Keller, Wen-Lu Li, Brian M. Fendly, William I. Wood, H. Michael Shepard & Christopher C. Benz. (1993) A Truncated Intracellular HER2/neu Receptor Produced by Alternative RNA Processing Affects Growth of Human Carcinoma Cells. Molecular and Cellular Biology 13:4, pages 2247-2257.
Read now
Read now
Alfredo R. Lopez, Julie Cook, Prescott L. Deininger & Rik Derynck. (1992) Dominant Negative Mutants of Transforming Growth Factor-βl Inhibit the Secretion of Different Transforming Growth Factor-β Isoforms. Molecular and Cellular Biology 12:4, pages 1674-1679.
Read now
Read now
Norbert Redemann, Bernhard Holzmann, Thomas Von Rüden, Erwin F. Wagner, Joseph Schlessinger & Axel Ullrich. (1992) Anti-Oncogenic Activity of Signalling-Defective Epidermal Growth Factor Receptor Mutants. Molecular and Cellular Biology 12:2, pages 491-498.
Read now
Read now
Maria Prat, Tiziana Crepaldi, Lucia Gandino, Silvia Giordano, Paola Longati & Paolo Comoglio. (1991) C-Terminal Truncated Forms of Met, the Hepatocyte Growth Factor Receptor. Molecular and Cellular Biology 11:12, pages 5954-5962.
Read now
Read now
Articles from other publishers (6)
Cecilia Ortíz, Santiago Ruatta & Marcelo Comini. 2022. Drug Target Selection and Validation. Drug Target Selection and Validation
61
82
.
John K. Chan, Huyen Pham, Xue Juan You, Noelle G. Cloven, Robert A. Burger, G. Scott Rose, Kristi Van Nostrand, Murray Korc, Philip J. DiSaia & Hung Fan. (2005) Suppression of Ovarian Cancer Cell Tumorigenicity and Evasion of Cisplatin Resistance Using a Truncated Epidermal Growth Factor Receptor in a Rat Model. Cancer Research 65:8, pages 3243-3248.
Crossref
Crossref
Rupert K Schmidt-Ullrich, Joseph N Contessa, Guido Lammering, George Amorino & Peck-Sun Lin. (2003) ERBB receptor tyrosine kinases and cellular radiation responses. Oncogene 22:37, pages 5855-5865.
Crossref
Crossref
Nicolas G Azios, Farida Jhabvala Romero, Michael C Denton, Joni K Doherty & Gail M Clinton. (2001) Expression of herstatin, an autoinhibitor of HER-2/neu, inhibits transactivation of HER-3 by HER-2 and blocks EGF activation of the EGF receptor. Oncogene 20:37, pages 5199-5209.
Crossref
Crossref
Patrick J Brennan, Toru Kumogai, Alan Berezov, Ramachandran Murali & Mark I Greene. (2000) HER2/Neu: mechanisms of dimerization/oligomerization. Oncogene 19:53, pages 6093-6101.
Crossref
Crossref
Dean B Reardon, Joseph N Contessa, Ross B Mikkelsen, Kristoffer Valerie, Cyrus Amir, Paul Dent & Rupert K Schmidt-Ullrich. (1999) Dominant negative EGFR-CD533 and inhibition of MAPK modify JNK1 activation and enhance radiation toxicity of human mammary carcinoma cells. Oncogene 18:33, pages 4756-4766.
Crossref
Crossref